[PDF][PDF] 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory …

…, T Hayashi, JD Katz, H Kohsaka… - Arthritis & …, 2017 - Wiley Online Library
Objective To develop and validate new classification criteria for adult and juvenile idiopathic
inflammatory myopathies (IIM) and their major subgroups. Methods Candidate variables …

Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides.

H Sakurai, H Kohsaka, MF Liu… - The Journal of …, 1995 - Am Soc Clin Investig
In this study, we have identified the source of nitric oxide (NO) produced in the human
inflammatory joints by analyzing expression of inducible NO synthase. In ex vivo organ cultures, …

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report

…, P Gordon, T Hayashi, JD Katz, H Kohsaka… - RMD open, 2017 - rmdopen.bmj.com
Objective To describe the methodology used to develop new classification criteria for adult
and juvenile idiopathic inflammatory myopathies (IIMs) and their major subgroups. Methods …

[HTML][HTML] miR-31 controls osteoclast formation and bone resorption by targeting RhoA

…, Y Murakami, T Saito, N Miyasaka, H Kohsaka - Arthritis research & …, 2013 - Springer
Introduction Increased activity of osteoclasts is responsible for bone loss and joint
destruction in rheumatoid arthritis. For osteoclast development and bone resorption activity, …

Amelioration of collagen-induced arthritis by blockade of inducible costimulator-B7 homologous protein costimulation

…, H Akiba, H Yagita, K Okumura, H Kohsaka… - The Journal of …, 2002 - journals.aai.org
B7 homologous protein (B7h)/B7-related protein 1 (B7RP-1) is a new member of the B7
family of costimulatory molecules that specifically interacts with inducible costimulator (ICOS) …

Drug free REmission/low disease activity after cessation of tocilizumab (Actemra) Monotherapy (DREAM) study

…, T Ishii, M Iwahashi, M Iwamoto, H Kohsaka… - Modern …, 2014 - Taylor & Francis
Objectives To investigate the duration of remission and low disease activity (LDA) after cessation
of tocilizumab (TCZ) treatment in rheumatoid arthritis patients who showed remission or …

Induction of the p16INK4a senescence gene as a new therapeutic strategy for the treatment of rheumatoid arthritis

K Taniguchi, H Kohsaka, N Inoue, Y Terada, H Ito… - Nature medicine, 1999 - nature.com
Synovial tissue affected by rheumatoid arthritis is characterized by proliferation, which leads
to irreversible cartilage and bone destruction. Current and experimental treatments have …

Current diagnosis and treatment of polymyositis and dermatomyositis

H Sasaki, H Kohsaka - Modern rheumatology, 2018 - academic.oup.com
Idiopathic inflammatory myopathies (IIMs) are heterogeneous disorders that affect the skeletal
muscles. Polymyositis, dermatomyositis, and inclusion body myositis are major IIM subsets…

[HTML][HTML] The multicenter study of a new assay for simultaneous detection of multiple anti-aminoacyl-tRNA synthetases in myositis and interstitial pneumonia

…, T Takeuchi, K Fujio, K Yamamoto, H Kohsaka… - PloS one, 2014 - journals.plos.org
Objective Autoantibodies to aminoacyl-tRNA synthetases (ARSs) are useful in the diagnosis
of idiopathic inflammatory myopathy (IIM) with interstitial pneumonia (IP). We developed an …

[PDF][PDF] Disease-association analysis of an inflammation-related feedback loop

…, S Shiraya, Y Nakatsuji, M Kinoshita, H Kohsaka… - Cell reports, 2013 - cell.com
The IL-6-triggered positive feedback loop for NFκB signaling (or the IL-6 amplifier/Inflammation
amplifier) was originally discovered as a synergistic-activation signal that follows IL-17/IL-…